BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: HIF1A antisense RNA 2 (HIF1A-AS2)

June 16, 2016 7:00 AM UTC

Patient sample and mouse studies suggest inhibiting HIF1A-AS2 could help treat glioblastoma multiforme (GBM). In GBM patients, HIF1A-AS2 levels were higher in tumors than in adjacent normal brain tiss...